8-K: Supernus Pharmaceuticals to Announce Second Quarter 2024 Financial Results on August 6

Supernus Pharmaceuticals will release its second quarter 2024 financial results after market close on August 6, 2024, followed by a conference call.

Summary

• Supernus Pharmaceuticals, a biopharmaceutical company specializing in central nervous system (CNS) treatments, will announce its second quarter 2024 financial results on August 6, 2024, after the market closes.
• The company will host a conference call and webcast on the same day at 4:30 p.m. ET to discuss the results.
• The conference call will include prepared remarks from management, a discussion of business results, and a question-and-answer session.
• A live webcast of the call will be available on the company's Investor Relations website, and a replay will be available for 60 days.

Sentiment

Score: 7

Explanation: The document is a routine announcement of an upcoming earnings release, which is generally neutral to positive. The company is providing clear communication to investors.

Positives

• The company is providing a clear timeline for the release of its second quarter 2024 results.
• A live webcast and replay will be available, increasing accessibility for investors.

Future Outlook

The company will discuss its second quarter 2024 business and financial results during the conference call.

Management Comments

• Jack Khattar, President and CEO, and Tim Dec, Senior Vice President and CFO, will host the conference call.

Industry Context

This announcement is a standard practice for publicly traded companies to communicate their financial performance to investors.

Comparison to Industry Standards

• The timing of the earnings release and conference call is consistent with industry practices for publicly traded pharmaceutical companies.
• Many companies in the pharmaceutical sector release quarterly results within a few weeks of the quarter's end, followed by a conference call to discuss the results with investors.

Stakeholder Impact

• Shareholders will receive an update on the company's financial performance.
• Investors will have the opportunity to ask questions during the conference call.

Next Steps

• Supernus Pharmaceuticals will report its second quarter 2024 financial results on August 6, 2024.
• The company will host a conference call and webcast on August 6, 2024, at 4:30 p.m. ET.

Key Dates

Keywords

Supernus Pharmaceuticals, Financial Results, Second Quarter 2024, Conference Call, Webcast, CNS, Biopharmaceutical, Investor Relations